Bokf, Na Intercept Pharmaceuticals, Inc. Transaction History

Bokf, Na

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2018 Nov 13, 2018	SELL	$88.49 - $127.55 $651,817 - $939,533	-7,366 Closed	0 $0
Q2 2018 Aug 13, 2018	BUY	$60.0 - $85.67 $170,160 - $242,960	2,836 Added 62.6%	7,366 $618,000
Q1 2018 May 14, 2018	BUY	$52.72 - $67.25 $238,821 - $304,642	4,530 New	4,530 $278,000

1.04M

30K

5.9K

Ticker ICPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,127,400
Description
Intercept Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat progressive non-viral liver diseases in the United States, Europe, and Canada. The company markets Ocaliva, a farnesoid X receptor agonist used for the treatment of primary biliary cholangitis in combination wit...

Get notified when there are updates to the investment portfolio of Bokf, Na, based on Form 13F filings with the SEC.

Stay updated on Bokf, Na with notifications on news.